IRIS

CARLOMAGNO, FRANCESCA

CARLOMAGNO, FRANCESCA  

DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE  

Mostra records
Risultati 1 - 20 di 121 (tempo di esecuzione: 0.041 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Molecular mechanisms of RET activation in human cancer 2.1 Contributo in volume (Capitolo o Saggio) 2002 Santoro, Massimo; Melillo, Rosa Marina; Carlomagno, F; Fusco, Alfredo; Vecchio, Giancarlo
Ret-mediated mitogenesis requires Src kinase activity. 1.1 Articolo in rivista 1999 Melillo, Rosa Marina; Barone, Mv; Lupoli, G; Cirafici, Am; Carlomagno, F; Visconti, R; Matoskova, B; Di Fiore, Pp; Vecchio, G; Fusco, Alfredo; Santoro, Massimo
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). 1.1 Articolo in rivista 2003 Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
The extent of linkage disequilibrium in four populations with distinct demographic histories 1.1 Articolo in rivista 2000 Dunning, Am; Durocher, F; Healey, Cs; Teare, Md; Mcbride, Se; Carlomagno, Francesca; Xu, Cf; Dawson, E; Rhodes, S; Ueda, S; Lai, E; Luben, Rn; VAN RENSBURG, Ej; Mannermaa, A; Kataja, V; Rennart, G; Dunhami, ; Purvis, I; Easton, D; Ponder, Ba
I geni oncosoppressori in "Patologia Generale" IV Ed, Pontieri-Russo-Frati 3.1 Monografia o trattato scientifico 2009 Santoro, Massimo; Carlomagno, F; Vecchio, Giancarlo
Different mutations of the RET gene cause different human tumoral diseases. 1.1 Articolo in rivista 1999 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; R., Visconti; DE VITA, Gabriella; G., Salvatore; Fusco, Alfredo; Vecchio, Giancarlo
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer. 1.1 Articolo in rivista 2013 De Falco, V; Buonocore, Preziosa; Muthu, M; Torregrossa, L; Basolo, F; Billaud, M; Gozgit, Jm; Carlomagno, Francesca; Santoro, Massimo
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. 1.1 Articolo in rivista 2001 Melillo, ROSA MARINA; Carlomagno, Francesca; DE VITA, Gabriella; Formisano, Pietro; Vecchio, Giancarlo; Fusco, Alfredo; Billaud, M.; Santoro, Massimo
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. 1.1 Articolo in rivista 1998 G., Tallini; Santoro, Massimo; M., Helie; Carlomagno, Francesca; G., Salvatore; G., Chiappetta; M. L., Carcangiu; Fusco, Alfredo
Thyroid cancer in 2010: A roadmap for targeted therapies 1.1 Articolo in rivista 2011 Carlomagno, Francesca; Santoro, Massimo
RET ONCOGENE ACTIVATION IN HUMAN THYROID NEOPLASMS IS RESTRICTED TO THE PAPILLARY CANCER SUBTYPE 1.1 Articolo in rivista 1992 Santoro, Massimo; Carlomagno, Francesca; Hay, I. D.; Herrmann, M. A.; Grieco, M.; Melillo, ROSA MARINA; Pierotti, M. A.; Bongarzone, I.; DELLA PORTA, G.; Berger, N.; Peix, J. L.; Paulin, C.; Fabien, N.; Vecchio, Giancarlo; Jenkins, R. B.; Fusco, Alfredo
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes 1.1 Articolo in rivista 2002 Carlomagno, Francesca; Vitagliano, Donata; Guida, Teresa; Napolitano, M.; Vecchio, Giancarlo; Fusco, Alfredo; Gazit, A.; Levitzki, A.; Santoro, Massimo
Genetic Alterations in differentiated thyroid cancer:what can be expected for gene expression profiling of thyroid carcinomas 1.1 Articolo in rivista 2003 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Castellone, MARIA DOMENICA; Vitagliano, Donata; Guida, Teresa; Vecchio, Giancarlo; Fusco, Alfredo
Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line. 1.1 Articolo in rivista 1995 Carlomagno, Francesca; Salvatore, Domenico; Santoro, Massimo; V. d., Franciscis; L., Quadro; L., Panariello; V., Colantuoni; Fusco, Alfredo
Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours. 1.1 Articolo in rivista 1993 M., Santoro; N., Sabino; Y., Ishizaka; T., Ushijima; Carlomagno, Francesca; A., Cerrato; M., Grieco; C., Battaglia; M. L., Martelli; C., Paulin
Constitutive and AP20187-induced ret activation in photoreceptors does not protect from light-induced damage 1.1 Articolo in rivista 2007 M., Allocca; U., Di Vicino; M., Petrillo; F., Carlomagno; L., Domenici; Auricchio, Alberto; Carlomagno, Francesca
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 1.1 Articolo in rivista 2000 De Vita, Gabriella; Melillo, Rosa Marina; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M.
Ret-mediated mitogenesis requires Src kinase activity. 1.1 Articolo in rivista 1999 Melillo, R. M.; Barone, M. V.; Lupoli, Gelsy; Cirafici, A. M.; Carlomagno, F.; Visconti, Roberta; Matoskova, B.; DI FIORE, P. P.; Vecchio, Giancarlo; Fusco, A.; Santoro, M.
Different mutations of the RET gene cause different human tumoral diseases. 1.1 Articolo in rivista 1999 Santoro, M.; Melillo, R. M.; Carlomagno, F.; Visconti, Roberta; DE VITA, Gabriella; Salvatore, Giuliana; Fusco, A.; Vecchio, Giancarlo
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 1.1 Articolo in rivista 1998 Carlomagno, F.; Melillo, Rosa Marina; Visconti, R.; Salvatore, G.; De Vita, Gabriella; Lupoli, G.; Yu, Y. B.; Jing, S. Q.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.